BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable Market

  November 5, 2024

   · 

  4 min read
• Press Releases

  Cencora Expands Enterprise Leadership Team with Two Senior Appointments

  November 5, 2024

   · 

  3 min read
• Press Releases

  AKURA MEDICAL SECURES FDA APPROVAL FOR US PIVOTAL TRIAL IN PULMONARY EMBOLISM

  November 5, 2024

   · 

  3 min read
• Press Releases

  Biotia Gets First-Ever NY State Regulatory Approval for a Urine Infectious Disease Test Powered by Genomics and AI

  November 5, 2024

   · 

  3 min read
• Press Releases

  Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis

  November 5, 2024

   · 

  5 min read
• Press Releases

  Neurocrine Biosciences Presents Breadth of Data Demonstrating Holistic Improvements Over Time in Patients With Tardive Dyskinesia Following Treatment With INGREZZA® (valbenazine) Capsules

  November 5, 2024

   · 

  17 min read
• Press Releases

  Sanguine Biosciences Announces the Launch of LeukoCert™ GMP Leukopaks

  November 5, 2024

   · 

  3 min read
• Press Releases

  Ondine Biomedical’s US $11M Fundraise Enables a Q4 2024 Start of Its Pivotal Phase 3 US Trial

  November 5, 2024

   · 

  2 min read
• Press Releases

  Neurogene Announces Oversubscribed $200 Million Private Placement

  November 5, 2024

   · 

  6 min read
• Press Releases

  Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease

  November 5, 2024

   · 

  5 min read